ATE514711T1 - Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen - Google Patents

Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen

Info

Publication number
ATE514711T1
ATE514711T1 AT07118566T AT07118566T ATE514711T1 AT E514711 T1 ATE514711 T1 AT E514711T1 AT 07118566 T AT07118566 T AT 07118566T AT 07118566 T AT07118566 T AT 07118566T AT E514711 T1 ATE514711 T1 AT E514711T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
preparation
galactosylated
diagnosing autoimmune
peptides
Prior art date
Application number
AT07118566T
Other languages
English (en)
Inventor
Maria Claudia Alcaro
Mario Chelli
Francesco Lolli
Paola Migliorini
Ilaria Paolini
Anna Maria Papini
Paolo Rovero
Original Assignee
Toscana Biomarkers S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toscana Biomarkers S R L filed Critical Toscana Biomarkers S R L
Application granted granted Critical
Publication of ATE514711T1 publication Critical patent/ATE514711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07118566T 2007-10-16 2007-10-16 Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen ATE514711T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07118566A EP2050761B1 (de) 2007-10-16 2007-10-16 Galactosylierte Peptide, deren Zubereitung und Verwendung zur Diagnose von Autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
ATE514711T1 true ATE514711T1 (de) 2011-07-15

Family

ID=39262610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07118566T ATE514711T1 (de) 2007-10-16 2007-10-16 Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen

Country Status (2)

Country Link
EP (1) EP2050761B1 (de)
AT (1) ATE514711T1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0916749D0 (en) 2009-09-23 2009-11-04 Mologic Ltd Peptide cleaning agents
CA3063325A1 (en) 2017-06-21 2018-12-27 Glykos Finland Oy Hydrophilic linkers and conjugates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla

Also Published As

Publication number Publication date
EP2050761A1 (de) 2009-04-22
EP2050761B1 (de) 2011-06-29

Similar Documents

Publication Publication Date Title
CY1113145T1 (el) Μορια υποδοχεα θυμικης στρωματικης λεμφοποιητινης και χρησεις αυτων
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
EA200901436A1 (ru) Антигенсвязывающие белки, связывающие par-2
TNSN08064A1 (en) Albumin fusion proteins
EP2650311A3 (de) Gegen heterodimere Cytokine und/oder deren Rezeptoren gerichtete Aminosäuresequenzen und Polypeptide damit
WO2011036445A3 (en) Polypeptides and uses thereof
EP2468773A3 (de) Anti-GM-CSF-Antikörper und Verwendungen dafür
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
BR0315327A (pt) Antagonistas de il-15
WO2008052173A8 (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
NZ599590A (en) Factor involved in latent infection with herpesvirus, and use thereof
DE60114018D1 (de) Von zellen präsentierte peptide
JP2008521795A5 (de)
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
ATE534909T1 (de) Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren
ATE514711T1 (de) Galactosylierte peptide, deren zubereitung und verwendung zur diagnose von autoimmunerkrankungen
MX2010005816A (es) Epítopos de péptido de stat3.
IL165364A (en) A method for identifying peptides that mimic an autoimmune antibody idiotype associated with autoimmune disease, peptides identified by the above method and their use
EP2292762A3 (de) VMP-artige Sequenzen von krankheitserregenden Borrelienspezies und -stämmen
DE69230614D1 (de) Protein-s polypeptide und deren verwendungen
CA2436779A1 (en) Human mitochondrial proteins and polynucleotides encoding the proteins
WO2002074793A3 (en) Novel peptides for the diagnosis of schizophrenia
BRPI0508895A (pt) formas polimorficas e amorfa de {2-flúor-5-[3-((e)-2-piridn-2-il-vinil)-1h-indazol-6-ilamin]- fenil}-amida de ácido 2,5-dimetil-2h-pirazol-3-carboxìlico
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties